Leading oncology research organization adopts Veeva Clinical Platform to enhance study delivery
Veeva Systems and Sarah Cannon Research Institute announced a strategic collaboration to drive speed and efficiency in oncology clinical trials across SCRI’s more than 200 research site locations. SCRI is adopting Veeva Clinical Platform to unify its contract research organization (CRO) and site management organization (SMO) on a single platform for seamless data flow across clinical teams and research sites.
Health Technology Insights: Nest Health Launches At-Home Program for Substance Use Treatment
“We are thrilled to advance our clinical trials by integrating Veeva Clinical Platform into our digital toolkit,” said SCRI chief information and digital officer Yazhene Krishnaraj. “This strategic collaboration empowers our clinical teams to deliver groundbreaking therapies to patients with enhanced precision and speed.”
Veeva Clinical Platform will enable SCRI to simplify and standardize trial processes and information flow, improving how investigators and clinical teams work together and share data. With a connected foundation for clinical research, SCRI will be able to automate key processes and provide a streamlined experience for its sites.
Health Technology Insights: Astrana Health Expands Leadership to Scale AI Healthcare Platform
“We’re excited to work closely with SCRI to drive innovation in oncology research,” said Jim Reilly, president of Veeva Development Cloud. “In a first-of-a-kind partnership, Veeva Clinical Platform will serve as SCRI’s clinical trial foundation for its CRO and SMO. By standardizing operations on one platform, we can support SCRI in delivering faster and more cost-effective trials.”
Health Technology Insights: Baxter to Offer Pieces’ AI Platform to Hospital Care Teams
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – PR Newswire
